title: Glomerular basement membrane selective permeability in short-term streptozotocin-induced diabetic rats.
abstract: In diabetes, the glomerular basement membrane undergoes thickening and structural alterations with loss of glomerular permselectivity properties. However, the onset of the alterations at early phases of diabetes is unclear. Aiming to determine the functional and structural alterations of the glomerular wall in the early stages of diabetes, we have studied the distribution of endogenous circulating albumin and type IV collagen in the glomerular basement membrane, using the immunocytochemical approach. The streptozotocin-injected hyperglycemic rat was our animal model. Renal tissues were examined after 10 days, 2, 4 and 6 months of hyperglycemia. Upon immunogold labelings, changes in the glomerular permeability to endogenous albumin were found altered as early as upon ten days of hyperglycemia. In contrast, no structural modifications were detected at this time point. Indeed, glomerular basement membrane thickening and an altered type IV collagen labeling distribution were only observed after four months of hyperglycemia, suggesting that functional alterations take place early in diabetes prior to any structural modification. In order to evaluate the reversibility of the glomerular alterations, two-month-old diabetic animals were treated with insulin. These animals showed a significant restoring of their glomerular permselectivity. Our results suggest a link between glycemic levels and alteration of glomerular permeability in early stages of diabetes, probably through high levels of glycated serum proteins.
authors.affiliation: Department of Pathology and Cell Biology, Université de Montréal, Québec, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Doucet
authors.forename: I
authors.initials: I
authors.lastname: Londoño
authors.forename: A
authors.initials: A
authors.lastname: Gómez-Pascual
authors.forename: M
authors.initials: M
authors.lastname: Bendayan
mesh_terms: D000818:Animals; D001485:Basement Membrane / Q000473:pathology / Q000502:physiology* / Q000648:ultrastructure; D002463:Cell Membrane Permeability / Q000502:physiology*; D003094:Collagen / Q000032:analysis / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000473:pathology / Q000503:physiopathology*; D006943:Hyperglycemia / Q000503:physiopathology; D007150:Immunohistochemistry; D007678:Kidney Glomerulus / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D016253:Microscopy, Immunoelectron; D051381:Rats; D017207:Rats, Sprague-Dawley; D012709:Serum Albumin / Q000378:metabolism; D013997:Time Factors
chemical_list: D012709:Serum Albumin; D003094:Collagen